The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.02 in the prior trading day, Tenaya Therapeutics Inc (NASDAQ: TNYA) closed at $1.97, down -2.48%. In other words, the price has decreased by -$2.48 from its previous closing price. On the day, 3.05 million shares were traded. TNYA stock price reached its highest trading level at $2.07 during the session, while it also had its lowest trading level at $1.91.
Ratios:
Our goal is to gain a better understanding of TNYA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.27 and its Current Ratio is at 5.27. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 16 ’24 when Saito Chihiro sold 2,363 shares for $2.89 per share. The transaction valued at 6,840 led to the insider holds 63,241 shares of the business.
Tingley Whittemore sold 7,428 shares of TNYA for $21,500 on Aug 16 ’24. The Chief Medical Officer now owns 107,106 shares after completing the transaction at $2.89 per share. On Aug 16 ’24, another insider, Ali Faraz, who serves as the Chief Executive Officer of the company, sold 9,748 shares for $2.89 each. As a result, the insider received 28,216 and left with 188,331 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 156064384 and an Enterprise Value of 91133416.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $7.01, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -2.22%, while the 200-Day Moving Average is calculated to be -45.23%.
Shares Statistics:
The stock has traded on average 1.71M shares per day over the past 3-months and 8637030 shares per day over the last 10 days, according to various share statistics. A total of 68.33M shares are outstanding, with a floating share count of 65.58M. Insiders hold about 17.22% of the company’s shares, while institutions hold 57.30% stake in the company. Shares short for TNYA as of 1730332800 were 5244350 with a Short Ratio of 3.06, compared to 1727654400 on 5076862. Therefore, it implies a Short% of Shares Outstanding of 5244350 and a Short% of Float of 9.4799995.
